[Form 4] ADTRAN Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
ADTRAN Holdings, Inc. (ADTN) reported an insider purchase of its common stock by a reporting person who is both a Director and the Chairman & CEO. On 11/24/2025, this individual acquired 40,928 shares of ADTRAN common stock in an open-market transaction coded as a purchase. The weighted average purchase price reported was $7.33 per share, with individual trades executed between $7.32 and $7.33.
Following this transaction, the reporting person beneficially owns 982,095.51 shares of ADTRAN common stock in direct form. The filing notes that detailed information on the number of shares purchased at each separate price within the stated range is available upon request.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 40,928 | $7.33 | $300K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.32 to $7.33, inclusive. The reporting person undertakes to provide to ADTRAN Holdings, Inc. (the Issuer), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
FAQ
What insider transaction did ADTRAN (ADTN) report in this Form 4?
The filing reports that a person who is both a Director and the Chairman & CEO of ADTRAN Holdings, Inc. purchased common stock of the company.
When did the ADTRAN (ADTN) insider transaction take place?
The transaction date shown in the Form 4 is 11/24/2025.
What does the weighted average price disclosure in the ADTRAN (ADTN) Form 4 mean?
It means the $7.33 price reflects an average of multiple trades executed between $7.32 and $7.33; the insider offers to provide the exact share counts at each price upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.